Stand 630 at Vitafoods International, Geneva, May 9 - 11 Cognis Nutrition & Health is a global supplier of high-quality, science-based, natural-source ingredients for food supplements and functional foods and beverages. Working in partnership with customers, we have the know-how to develop innovative new products and concepts, providing marketing insight, technical, regulatory and scientific expertise from initial concept through to launch and market success. Products featured at the Show include: Tonalin® CLA, conjugated linoleic acid* for body composition; Vegapure® plant sterols and sterol esters for heart health, including a new food supplement application for Vegapure® FTE free plant sterols; and Xangold® natural lutein esters for eye health. Cognis Nutrition & Health will also present at the event Conference on 10th May, on 'Beauty foods for lifelong, visible vitality'. Visit the Seminar Theatre on 11 May (11:40) to hear the results of recent research on Tonalin® CLA. Contact: email@example.com. www.cognis.com About Cognis Cognis is a worldwide supplier of innovative specialty chemicals and nutritional ingredients. The company employs about 8,000 people, and it operates production sites and service centers in 30 countries. Cognis has dedicated its activities to a high level of sustainability and delivers natural source raw materials and ingredients for food, nutrition and healthcare markets, and the cosmetics, detergents and cleaners industries. Another main focus is on products for a number of other industries, such as coatings and inks, lubricants, textiles, as well as agriculture and mining. The company holds a 50-percent stake in Cognis Oleochemicals, one of the world's leading manufacturers of natural-source oleochemical basestocks. Cognis is owned by private equity funds advised by Permira, GS Capital Partners, and SV Life Sciences. In 2005, Cognis recorded sales of 3.18 billion euros and an Adjusted EBITDA (earnings before interest, income taxes, depreciation, amortization and exceptional items) of 356 million euros.